Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Adv Ther ; 37(8): 3642, 2020 08.
Article in English | MEDLINE | ID: mdl-32557269

ABSTRACT

In the original article, there is an error in age related reference.

2.
Adv Ther ; 37(Suppl 2): 121-126, 2020 05.
Article in English | MEDLINE | ID: mdl-32236878

ABSTRACT

X-linked hypophosphataemia (XLH) rickets is a rare disease frequently misdiagnosed and mismanaged. Despite having clinical guidelines that offers some therapeutic recommendations based on the clinical experience of experts, physicians still have questions about some important aspects of the diagnosis and treatment of XLH, such as when the disease should be suspected, who should be in charge of the diagnosis, what should be done once the disease is diagnosed, or what therapeutic options are currently available. The objective of this paper is to answer some of the more frequent questions related to the management of patients with XLH by a group of experts participating in a scientific conference on XLH held in Madrid.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Drug Therapy/standards , Familial Hypophosphatemic Rickets/diagnosis , Familial Hypophosphatemic Rickets/drug therapy , Practice Guidelines as Topic , Adolescent , Child , Child, Preschool , Drug Dosage Calculations , Female , Fibroblast Growth Factor-23 , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...